Vanguard Group Inc Novo Cure LTD Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Vanguard Group Inc holds 10,023,981 shares of NVCR stock, worth $172 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,023,981
Previous 9,759,098
2.71%
Holding current value
$172 Million
Previous $146 Million
7.53%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NVCR
# of Institutions
277Shares Held
73.2MCall Options Held
1.43MPut Options Held
832K-
Black Rock Inc. New York, NY9.08MShares$156 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.86MShares$152 Million0.03% of portfolio
-
State Street Corp Boston, MA3.36MShares$57.6 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.38MShares$40.8 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA2.31MShares$39.5 Million0.01% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.8B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...